open access

Vol 85, No 5 (2014)
ARTICLES
Get Citation

Tocolysis in preterm labour – current recommendations

Mirosław Wielgoś, Dorota A. Bomba-Opoń
DOI: 10.17772/gp/1732
·
Ginekol Pol 2014;85(5).

open access

Vol 85, No 5 (2014)
ARTICLES

Abstract

Common use of tocolytic drugs in preterm labor has not been shown to reduce the rate of neonatal mortality and morbidity. Currently, tocolytics should be administered in the course of a 48-h administration of antepartum glucocorticoids and/or transfer of the gravida to a center with neonatal intensive care unit. Only oxytocin receptor antagonist – atosiban and short-acting beta-agonists – fenoterol are licensed to reduce preterm uterine activity. Owing to its safety and efficacy, atosiban should be the first-choice tocolytic, especially in women with other diseases or multiple gestations.Tokoliza w porodzie przedwczesnym – aktualne wytyczne

Abstract

Common use of tocolytic drugs in preterm labor has not been shown to reduce the rate of neonatal mortality and morbidity. Currently, tocolytics should be administered in the course of a 48-h administration of antepartum glucocorticoids and/or transfer of the gravida to a center with neonatal intensive care unit. Only oxytocin receptor antagonist – atosiban and short-acting beta-agonists – fenoterol are licensed to reduce preterm uterine activity. Owing to its safety and efficacy, atosiban should be the first-choice tocolytic, especially in women with other diseases or multiple gestations.Tokoliza w porodzie przedwczesnym – aktualne wytyczne
Get Citation
About this article
Title

Tocolysis in preterm labour – current recommendations

Journal

Ginekologia Polska

Issue

Vol 85, No 5 (2014)

DOI

10.17772/gp/1732

Bibliographic record

Ginekol Pol 2014;85(5).

Authors

Mirosław Wielgoś
Dorota A. Bomba-Opoń

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl